Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124265312 | 12426531 | 2 | F | 20140605 | 20160831 | 20160601 | 20160907 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-34366BI | BOEHRINGER INGELHEIM | 70.79 | YR | M | Y | 0.00000 | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124265312 | 12426531 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | U | 22512 | 150 | MG | CAPSULE | BID | |||||
| 124265312 | 12426531 | 2 | C | LEVEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
| 124265312 | 12426531 | 3 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 100 MG | 0 | 50 | MG | TABLET | BID | ||||||
| 124265312 | 12426531 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG | 0 | 1 | MG | TABLET | QD | ||||||
| 124265312 | 12426531 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 2000 MG | 0 | 1000 | MG | TABLET | BID | ||||||
| 124265312 | 12426531 | 6 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG | 0 | 50 | MG | TABLET | QD | ||||||
| 124265312 | 12426531 | 7 | C | CYANOCOBALAMIN (VITAMIN B-12) | 2 | Oral | 1000 MCG | 0 | 1000 | UG | TABLET | QD | |||||||
| 124265312 | 12426531 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MCG | 0 | 20 | UG | QD | |||||||
| 124265312 | 12426531 | 9 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 650 MCG | 0 | 325 | UG | TABLET | BID | ||||||
| 124265312 | 12426531 | 10 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 500 MG | 0 | 500 | MG | TABLET | QD | ||||||
| 124265312 | 12426531 | 11 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | TR 24 1 TAB | 0 | 5 | MG | TABLET | |||||||
| 124265312 | 12426531 | 12 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124265312 | 12426531 | 1 | Atrial fibrillation |
| 124265312 | 12426531 | 2 | Diabetes mellitus |
| 124265312 | 12426531 | 3 | Blood pressure abnormal |
| 124265312 | 12426531 | 5 | Diabetes mellitus |
| 124265312 | 12426531 | 6 | Mood altered |
| 124265312 | 12426531 | 7 | Vitamin B12 deficiency |
| 124265312 | 12426531 | 11 | Diabetes mellitus |
| 124265312 | 12426531 | 12 | Benign prostatic hyperplasia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124265312 | 12426531 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124265312 | 12426531 | Gastrointestinal haemorrhage | |
| 124265312 | 12426531 | Haemorrhagic anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124265312 | 12426531 | 1 | 20131011 | 0 |